Latest News

AB Science SA today announced the publication of a peer-reviewed article in which the authors state that blocking hemichannels on mast cells with masitinib represents a promising novel strategy for slowing the progression of neurodegenerative diseases such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). Hemichannels allow cell communication with...
Researchers from the Princess Máxima Center, the Netherlands Cancer Institute, and Oncode Institute have unearthed valuable knowledge about the origin of rhabdoid tumors, an aggressive form of cancer diagnosed in children, through studying mini, lab-grown tumors. Their research has managed to identify a potential target for future therapies.   Utrecht,...
COPENHAGEN – A grant from the Novo Nordisk Foundation of up to 300 million euros now enables the establishment of a major international research center focused on stem cell medicine. The center will be a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands. The partnership...
PHILADELPHIA – New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN, led the study which looked...
Patient-reported analyses demonstrated greater reduction in both cognitive and motor-related disease burden for INGREZZA compared with placebo Findings to be presented at the 2025 Advanced Therapeutics in Movement & Related Disorders (ATMRD) Congress SAN DIEGO, Calif. — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new patient-reported post-hoc data from the KINECT®-HD study highlighting significant reductions in...